Cutting-edge artificial intelligence platform to analyze antipsychotic drug use data from leading brain development institute to predict patient outcomes. WASHINGTON DC, and BALTIMORE, MD – Feb. 15th, 2018 ― BullFrog…
Continue Reading
Cutting-edge artificial intelligence platform to analyze antipsychotic drug use data from leading brain development institute to predict patient outcomes. WASHINGTON DC, and BALTIMORE, MD – Feb. 15th, 2018 ― BullFrog…